tirzepatide ada Efficacy of in People with Young-Onset T2D in the SURPASS Program Tirzepatide Tier 1 Maintenance Dosing

Description

During the same period, obesity without T2DM notably increased from 10 to 31%

Made with natural ingredients to soothe and balance your gut, its the perfect companion for anyone using GLP-1 medications or looking to feel their best every day

Get expert-backed tips on managing withdrawal symptoms and maintaining your progress.

In university, we focus mostly on the actual drug, while in practice, doctors usually write the brand names on the prescription

Current annual therapy cost: ~1.51.7 lakh per patient At 5060% lower pricing: ~70,00085,000 per year Savings of nearly 80,0001,00,000 per patient annually Now consider scale: 100,000 patients 75,000 750 crore annual market 500,000 patients (just ~0.5% of high-risk obese population) 3,750 crore opportunity And thats only drug revenue